Dr. med. Dr. oec. Richard Ammer, born in Munich, graduated in medicine (Technical University Munich, Harvard Medical School Boston). His basic and clinical research on atrial fibrillation for which he obtained his PhD was awarded by the European Society in Cardiology with the Young Investigator Award in Basic Science in 2001 (Stockholm).
Specializing in cardiac and renal care Dr. Ammer pursued his clinical education in internal medicine at Massachusetts General Hospital in Boston (1996-2000), the German Heart Center (2000-2001) and the University Hospital in Muenster (since 2001), where today he is responsible for patients undergoing dialysis and renal transplant and where he runs the anemia unit. He also established the nation-wide network of excellence and competence on cardiac arrhythmias (BMBF sponsored) which he ran as general manager from 2002 to 2004 www.kompetenznetze-medizin.de.
His studies in business administration and economics he pursued at University St. Gallen (1992-1996), and Harvard Extension School (1996 -1999) completing his PhD in 2005. Since 2001 Dr. Ammer is assistant professor at University St. Gallen (CH).
In the family-owned pharmaceutical company MEDICE Dr. Ammer is active as managing owner, as general manager since 2003 responsible for search & development, medical & regulatory affairs, manufacturing, market access and international marketing & distribution.
In parallel, since 2006 Dr. Ammer is board member and VP of the German Pharmaceutical Association with a focus on R&D www.BPI.de